Biotech · Private company
Natera, Inc.
Track this companyFree. Adds Natera, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- ctDNA-Guided Treatment StrategyBreast NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- Signatera Genome ultra-sensitive ctDNA blood testEndometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
- Single-gene Noninvasive Prenatal Testing (sgNIPT)Single Gene NIPTClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast CancerPHASE1_PHASE2 · NOT_YET_RECRUITING · started Jan 15, 2027ClinicalTrials.gov NCT07217990 · fetched Nov 12, 2026
- TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell LymphomaPHASE2 · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07502872 · fetched Nov 12, 2026
- Risk-Enabled Therapy After Initiating EV/Pembro for Bladder CancerPHASE2 · RECRUITING · started Oct 16, 2026ClinicalTrials.gov NCT07908979 · fetched Nov 12, 2026
- Signatera Assessment in Early-Stage Endometrial CancerNA · NOT_YET_RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07339384 · fetched Nov 12, 2026
- ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin LymphomaPHASE2 · RECRUITING · started Aug 18, 2026ClinicalTrials.gov NCT07021989 · fetched Nov 12, 2026
- Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)RECRUITING · started Jul 27, 2026ClinicalTrials.gov NCT07750886 · fetched Nov 12, 2026
- Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)RECRUITING · started Jul 27, 2026ClinicalTrials.gov NCT07763197 · fetched Nov 12, 2026
- AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal AdenocarcinomasPHASE2 · RECRUITING · started Jul 20, 2026ClinicalTrials.gov NCT07290985 · fetched Nov 12, 2026
- Circulating Tumor DNA in Stage I, II, and III Germ-Cell TumorsNA · RECRUITING · started Jun 3, 2026ClinicalTrials.gov NCT07401316 · fetched Nov 12, 2026
- Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerNA · RECRUITING · started May 8, 2026ClinicalTrials.gov NCT07214532 · fetched Nov 12, 2026
- Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer ScreeningRECRUITING · started Feb 12, 2026ClinicalTrials.gov NCT07195071 · fetched Nov 12, 2026
- Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual DiseasePHASE1 · RECRUITING · started Mar 20, 2025ClinicalTrials.gov NCT06529822 · fetched Nov 12, 2026
- Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCLPHASE2 · RECRUITING · started Jun 18, 2024ClinicalTrials.gov NCT06500273 · fetched Nov 12, 2026
- EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)RECRUITING · started Jan 25, 2024ClinicalTrials.gov NCT06808880 · fetched Nov 12, 2026
- Trifecta-Lung cfDNA-MMDx StudyRECRUITING · started Nov 1, 2023ClinicalTrials.gov NCT05837663 · fetched Nov 12, 2026
- Evaluating Novel Therapies in ctDNA Positive GI CancersPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 29, 2023ClinicalTrials.gov NCT05482516 · fetched Nov 12, 2026
- Colon Adjuvant Chemotherapy Based on Evaluation of Residual DiseasePHASE2_PHASE3 · RECRUITING · started Jul 8, 2022ClinicalTrials.gov NCT05174169 · fetched Nov 12, 2026
- ctDNA Assay in Patients With Resectable Pancreatic CancerRECRUITING · started May 25, 2022ClinicalTrials.gov NCT05052671 · fetched Nov 12, 2026
- Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit SurgeryACTIVE_NOT_RECRUITING · started Apr 19, 2022ClinicalTrials.gov NCT05914792 · fetched Nov 12, 2026
- Adaptive Radiation for Locally Advanced Rectal AdenocarcinomaEARLY_PHASE1 · ACTIVE_NOT_RECRUITING · started Dec 23, 2021ClinicalTrials.gov NCT05108428 · fetched Nov 12, 2026
- Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal CancerRECRUITING · started Sep 3, 2021ClinicalTrials.gov NCT05081024 · fetched Nov 12, 2026
- Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon AdenocarcinomasPHASE1 · RECRUITING · started Aug 26, 2021ClinicalTrials.gov NCT04920032 · fetched Nov 12, 2026
- Trifecta-Heart cfDNA-MMDx StudyRECRUITING · started Jun 1, 2021ClinicalTrials.gov NCT04707872 · fetched Nov 12, 2026
- Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal CancerPHASE1 · RECRUITING · started Feb 11, 2021ClinicalTrials.gov NCT04703101 · fetched Nov 12, 2026
- Trifecta-Kidney cfDNA-MMDx StudyRECRUITING · started Dec 1, 2019ClinicalTrials.gov NCT04239703 · fetched Nov 12, 2026